CCND1 and prostate cancer: Nuclear paxillin has also been observed to increase cell proliferation via transcription of Cyclin D1 in prostate cancer cells, by acting as a nuclear scaffold, to promote extracellular-regulated kinase (ERK) phosphorylation of the ETS domain-containing protein (Elk-1) [20].